{"id":"https://openalex.org/W2133671844","doi":"https://doi.org/10.1111/j.1755-5949.2007.00034.x","title":"GABAA Receptor Subtype\u2010Selective Efficacy: TPA023, an \u03b12/\u03b13 Selective Non\u2010sedating Anxiolytic and \u03b15IA, an \u03b15 Selective Cognition Enhancer","display_name":"GABAA Receptor Subtype\u2010Selective Efficacy: TPA023, an \u03b12/\u03b13 Selective Non\u2010sedating Anxiolytic and \u03b15IA, an \u03b15 Selective Cognition Enhancer","alternate_titles":[],"publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W2133671844","doi":"https://doi.org/10.1111/j.1755-5949.2007.00034.x","mag":"2133671844","pmid":"https://pubmed.ncbi.nlm.nih.gov/18482097","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6494020"},"language":"en","primary_location":{"id":"doi:10.1111/j.1755-5949.2007.00034.x","doi":"https://doi.org/10.1111/j.1755-5949.2007.00034.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1755-5949.2007.00034.x","pdf_url":null,"source":{"id":"https://openalex.org/S84392608","display_name":"CNS Neuroscience & Therapeutics","issn_l":"1755-5930","issn":["1755-5930","1755-5949"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neuroscience &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2133671844"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3458.2007.00034.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027021273","display_name":"John R. Atack","orcid":"https://orcid.org/0000-0002-3410-791X","observed_orcids":["https://orcid.org/0000-0002-3410-791X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John R. Atack","raw_affiliation_strings":["Neuroscience, Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium. JAtack1@prdbe.jnj.com","Neuroscience, Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience, Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium. JAtack1@prdbe.jnj.com","institution_ids":[]},{"raw_affiliation_string":"Neuroscience, Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5027021273"],"corresponding_institution_ids":[],"apc_list":{"value":4140,"currency":"USD","value_usd":4140},"apc_paid":null,"fwci":3.0729,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.91384439,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"14","issue":"1","first_page":"25","last_page":"35"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gabaa-receptor-subtypes","display_name":"GABAA receptor subtypes","score":0.8560000061988831},{"id":"https://openalex.org/keywords/nootropics","display_name":"nootropic drugs","score":0.8119999766349792},{"id":"https://openalex.org/keywords/inverse-agonists","display_name":"inverse agonists","score":0.7630000114440918},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.9559999704360962},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.7549999952316284},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.953000009059906},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.9739999771118164},{"id":"https://openalex.org/keywords/alcohol-induced-cognitive-impairment","display_name":"alcohol-induced cognitive impairment","score":0.8339999914169312},{"id":"https://openalex.org/keywords/memory-enhancement","display_name":"memory enhancement","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6287965774536133},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6263777017593384},{"id":"https://openalex.org/C2781269603","wikidata":"https://www.wikidata.org/wiki/Q899683","display_name":"Isoxazole","level":2,"score":0.5754130482673645},{"id":"https://openalex.org/C2779706987","wikidata":"https://www.wikidata.org/wiki/Q408265","display_name":"Lorazepam","level":2,"score":0.5423105955123901},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.5413693189620972},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.5152135491371155},{"id":"https://openalex.org/C89951826","wikidata":"https://www.wikidata.org/wiki/Q1671731","display_name":"Inverse agonist","level":4,"score":0.4821719527244568},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4425416886806488},{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.41004300117492676},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3651205897331238},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3550010919570923},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3044629991054535},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23306700587272644},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.12281343340873718},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.10339540243148804}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018755","descriptor_name":"GABA Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1111/j.1755-5949.2007.00034.x","doi":"https://doi.org/10.1111/j.1755-5949.2007.00034.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1755-5949.2007.00034.x","pdf_url":null,"source":{"id":"https://openalex.org/S84392608","display_name":"CNS Neuroscience & Therapeutics","issn_l":"1755-5930","issn":["1755-5930","1755-5949"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neuroscience &amp; Therapeutics","raw_type":"journal-article"},{"id":"doi:10.1111/j.1527-3458.2007.00034.x","doi":"https://doi.org/10.1111/j.1527-3458.2007.00034.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1527-3458.2007.00034.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3458.2007.00034.x","source":{"id":"https://openalex.org/S84392608","display_name":"CNS Neuroscience & Therapeutics","issn_l":"1755-5930","issn":["1755-5930","1755-5949"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neuroscience &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5559778","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6494020","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:18482097","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18482097","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS neuroscience & therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6494020","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6494020/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neurosci Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1527-3458.2007.00034.x","doi":"https://doi.org/10.1111/j.1527-3458.2007.00034.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1527-3458.2007.00034.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3458.2007.00034.x","source":{"id":"https://openalex.org/S84392608","display_name":"CNS Neuroscience & Therapeutics","issn_l":"1755-5930","issn":["1755-5930","1755-5949"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neuroscience &amp; Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2133671844.pdf"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W20326315","https://openalex.org/W95041057","https://openalex.org/W1565551672","https://openalex.org/W1705744169","https://openalex.org/W1966837740","https://openalex.org/W1969130118","https://openalex.org/W1973173016","https://openalex.org/W1980798138","https://openalex.org/W1985881933","https://openalex.org/W2001619275","https://openalex.org/W2011620653","https://openalex.org/W2016154588","https://openalex.org/W2016652516","https://openalex.org/W2016940189","https://openalex.org/W2020117882","https://openalex.org/W2020200168","https://openalex.org/W2025429574","https://openalex.org/W2032953709","https://openalex.org/W2036204342","https://openalex.org/W2037139658","https://openalex.org/W2039738625","https://openalex.org/W2042887680","https://openalex.org/W2044007321","https://openalex.org/W2055569334","https://openalex.org/W2057137756","https://openalex.org/W2062186332","https://openalex.org/W2071973373","https://openalex.org/W2078681603","https://openalex.org/W2080639248","https://openalex.org/W2081822887","https://openalex.org/W2083623577","https://openalex.org/W2084906880","https://openalex.org/W2087519774","https://openalex.org/W2090116461","https://openalex.org/W2097643979","https://openalex.org/W2101030003","https://openalex.org/W2106001183","https://openalex.org/W2106915249","https://openalex.org/W2111020794","https://openalex.org/W2112805640","https://openalex.org/W2115041711","https://openalex.org/W2121060688","https://openalex.org/W2121237571","https://openalex.org/W2129874579","https://openalex.org/W2139230578","https://openalex.org/W2143086898","https://openalex.org/W2151414518","https://openalex.org/W2163056684","https://openalex.org/W2164205049","https://openalex.org/W2165223719","https://openalex.org/W2165531892","https://openalex.org/W2169205273","https://openalex.org/W2203342607","https://openalex.org/W2404476850","https://openalex.org/W2409680994","https://openalex.org/W2418722848","https://openalex.org/W2951249843","https://openalex.org/W4246109793"],"related_works":["https://openalex.org/W1520508152","https://openalex.org/W4246109793","https://openalex.org/W41628817","https://openalex.org/W2064596734","https://openalex.org/W2061159864","https://openalex.org/W2121060688","https://openalex.org/W2060402638","https://openalex.org/W2024017841","https://openalex.org/W2203342607"],"abstract_inverted_index":{"TPA023":[0,15,49,87,121,139,224,245],"and":[1,24,56,80,94,112,154,206,240,246],"alpha5IA":[2,28,59,97,135,179,187,193,226,247],"are":[3],"structurally":[4],"related":[5],"compounds":[6],"that":[7,86],"selectively":[8],"modulate":[9],"certain":[10],"GABA(A)":[11,254],"receptor":[12],"subtypes.":[13],"Hence,":[14],"has":[16,29,230],"weak":[17],"partial":[18],"agonist":[19,31,146],"efficacy":[20,32,38,220],"at":[21,33,234],"the":[22,34,68,102,105,126,132,144,174,184,211,235,238,249],"alpha2":[23],"alpha3":[25],"subtypes":[26],"whereas":[27,58,96,131],"inverse":[30,76],"alpha5":[35],"subtype.":[36],"These":[37],"characteristics":[39],"translate":[40],"into":[41],"novel":[42],"pharmacological":[43],"profiles":[44],"in":[45,54,62,81,116,125,148,180,188,196,202,227],"preclinical":[46,117,239],"species":[47],"with":[48,74,244],"being":[50],"a":[51,123],"nonsedating":[52],"anxiolytic":[53],"rats":[55,63],"primates":[57],"enhanced":[60],"cognition":[61],"but":[64],"was":[65,88,98,109,136,140,194,207],"devoid":[66],"of":[67,107,128,134,150,173,178,186,214,251],"proconvulsant":[69],"or":[70,169,225],"kindling":[71],"liabilities":[72],"associated":[73],"nonselective":[75,145],"agonists.":[77],"In":[78,119],"vitro":[79],"vivo":[82],"metabolic":[83],"studies":[84],"showed":[85],"metabolized":[89,99],"via":[90],"CYP3A4-mediated":[91],"t-butyl":[92],"hydroxylation":[93],"N-deethylation":[95],"to":[100,209],"produce":[101],"hydroxymethyl":[103,175],"isoxazole,":[104],"latter":[106],"which":[108],"highly":[110],"insoluble":[111],"caused":[113],"renal":[114],"toxicity":[115],"species.":[118],"humans,":[120],"had":[122],"half-life":[124,133],"region":[127],"6-7":[129],"h":[130],"2-2.5":[137],"h.":[138],"clearly":[141],"differentiated":[142],"from":[143],"lorazepam":[147],"terms":[149],"saccadic":[151],"eye":[152],"movement":[153],"unlike":[155],"lorazepam,":[156],"it":[157],"did":[158],"not":[159],"impair":[160],"either":[161,223],"postural":[162],"stability,":[163],"as":[164],"judged":[165],"by":[166],"body":[167],"sway,":[168],"cognition.":[170],"The":[171],"occurrence":[172],"isoxazole":[176],"metabolite":[177],"human":[181],"urine":[182],"precluded":[183],"use":[185],"prolonged":[189],"dosing":[190],"studies.":[191],"Nevertheless,":[192],"evaluated":[195],"an":[197],"alcohol-induced":[198],"cognitive":[199],"impairment":[200],"model":[201],"healthy":[203],"normal":[204],"volunteers":[205],"found":[208],"reverse":[210],"memory-impairing":[212],"effects":[213],"alcohol.":[215],"To":[216],"date,":[217],"however,":[218],"no":[219],"data":[221,243],"for":[222],"patient":[228],"populations":[229],"been":[231],"reported,":[232],"although":[233],"very":[236],"least,":[237],"limited":[241],"clinical":[242],"validate":[248],"approach":[250],"targeting":[252],"specific":[253],"receptors":[255],"through":[256],"subtype-selective":[257],"efficacy.":[258]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2133671844","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
